NanJing Pharmaceutical Co Ltd
SSE:600713
Relative Value
The Relative Value of one NanJing Pharmaceutical Co Ltd stock under the Base Case scenario is 22.95 CNY. Compared to the current market price of 4.86 CNY, NanJing Pharmaceutical Co Ltd is Undervalued by 79%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
NanJing Pharmaceutical Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
NanJing Pharmaceutical Co Ltd
SSE:600713
|
6.3B CNY | 0.1 | 11.1 | 8.3 | 8.3 | ||
US |
Mckesson Corp
NYSE:MCK
|
69.5B USD | 0.2 | 23.2 | 16.1 | 18.7 | ||
US |
Cencora Inc
NYSE:COR
|
44.8B USD | 0.2 | 24 | 12.3 | 17.3 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
25.1B USD | 0.1 | 39.3 | 8.8 | 11.8 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 21.3 | 11.3 | 15.2 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 1.4 | 21.3 | 15.5 | 15.5 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
60.6B HKD | 0.1 | 6.3 | 1.5 | 1.8 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 3.1 | 45.8 | 14.8 | 29.2 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.2 | 13.5 | 8 | 8 |